Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors

Acta Pharmacologica Sinica

Volumn 26, Issue 6, 2005, Pages 685-690

  Hu, Hua ^a,b   Chen, Gao ^a   Zhang, Jian Min ^a   Zhang, Wei Ping ^b   Zhang, Lei ^b   Ge, Qiu Fu ^b   Yao, Hong Tian ^a   Ding, Wei ^a   Chen, Zhong ^b   Wei, Er Qing ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Brain injuries; Brain neoplasms; Cysteinyl leukotriene receptor 2; Vascular smooth muscle cell

Indexed keywords

CYSTEINYLLEUKOTRIENE RECEPTOR 2; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BRAIN INJURY; BRAIN MICROCIRCULATION; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIA; GRANULOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INFLAMMATION; MALE; NERVE CELL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN; BRAIN INJURIES; BRAIN NEOPLASMS; ENDOTHELIAL CELLS; FEMALE; GANGLIOGLIOMA; GRANULOCYTES; HUMANS; MALE; MEMBRANE PROTEINS; MICROCIRCULATION; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, LEUKOTRIENE;

EID: 20444397785     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00092.x     Document Type: Article

References (23)

1. Borish L. The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 2002; 88: 16-22.
2. Fujita M, Yonetomi Y, Shimouchi K, Takeda H, Aze Y, Kawabata K, et al. Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs. Eur J Pharmacol 1999; 369: 349-56.
3. Storms WW. Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy Asthma Immunol 2003; 91: 131-40.
4. Shinonaga M, Chang CC, Kuwabara T. Relation between macrophage infiltrates and peritumoral edema. Adv Neurol 1990; 52: 475-81.
5. Schuhmann MU, Mokhtarzadeh M, Stichtenoth DO, Skardelly M, Klinge PM, Gutzki FM, et al. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. Neurol Res 2003; 25: 481-91.
6. Ciceri P, Rabuffetti M, Monopoli A, Nicosia S. Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol 2001; 133: 1323-9.
7. 4 contents, synthase and catabolic activity in human meningiomas. Neurol Res 1992; 14: 405-10.
8. 1 receptor. Nature 1999; 399: 789-93.
9. Sarau HM, Ames RS, Chambers J, Ellis C, Elshourbagy N, Foley JJ, et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 1999; 56: 657-63.
10. 2 receptor. Biochem Biophys Res Commun 2000; 274: 316-22.
11. 2 receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 2001; 276: 47489-95.
12. Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000; 275: 30531-6.
13. Zhang WP, Hu H, Zhang L, Ding W, Yao HT, Chen KD, et al. Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neurosci Lett 2004; 363: 247-51.
14. Zhang WP, Wei EQ, Mei RH, Zhu CY, Zhao MH. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol Sin 2002; 23: 871-7.
15. 2 receptor on human coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001; 287: 1088-92.
16. 2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: e37-41.
17. Lotzer K, Spanbroek R, Hildner M, Urbach A, Heller R, Bretschneider E, et al. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 2003; 23: e32-6.
18. Beller TC, Maekawa A, Friend DS, Austen KF, Kanaoka Y. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem 2004; 279: 46129-34.
19. 1 receptors and mitogen-activated protein kinase pathway. Eur J Neurosci 2004; 20: 1514-24.
20. 4 activates MAPK through a ras-independent but PKC ε-dependent pathway in intestinal epithelial cells. J Cell Sci 2002; 115: 1883-93.
21. Beller TC, Friend DS, Maekawa A, Lam BK, Austen KF, Kanaoka Y. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci USA 2004; 101: 3047-52.
22. Evans JF. Cysteinyl leukotriene receptors. Prostaglandins Lipid Mediators 2002; 68-69: 587-97.
23. Di Gennaro A, Carnini C, Buccellati C, Ballerio R, Zarini S, Fumagalli F, et al. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: A role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB J 2004; 18: 842-4.